Real-World Use Of Ultrathin-Strut Biodegradable Polymer-Coated Sirolimus-Eluting Stents In Patients With Coronary Artery Disease: 6-Month Clinical Outcomes.

Prakash AjmeraRamesh PothineniKamal Kumar ChawlaSai Sudhakar MantravadiPankaj Vinod JariwalaVinod VijanVikrant Vijan

Published in: Vascular health and risk management (2019)

The results of the current registry outline the safety and effectiveness of the Tetriflex SES in real-world patients, as it displayed favorable clinical outcomes at 6-month follow-up, with low incidence of TLR and stent thrombosis.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
systematic review
drug delivery
inflammatory response
immune response
risk factors
peritoneal dialysis
prognostic factors
pulmonary embolism
patient reported